Investor Relations Contact

Investor relations contact

CEO

ExpreS²ion Biotechnologies
Agern Allé 1
DK-2970 Hørsholm
Denmark

E-mail: buf(at)expres2ionbio.com

IPO and Rights Issues

Corporate governance

ExpreS²ion Biotech Holding AB
c/o Mazars SET, Terminalgatan 1, 252 24 Helsingborg, Sweden

E-mail: info(a)expres2ionbio.com
Phone: +45 2222 1019

Cookies help us deliver our services.
By using our services, you agree to our use of cookies. Got it!